Ziprasidone Hydrochloride
- Product NDC
- 68071-3563
- 11-digit product format
- 680713563
- Labeler code
- 68071
- Product ID
- 68071-3563_0fcead61-ddda-bcef-e063-6394a90af8a4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ziprasidone Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA204117
- Marketing category
- ANDA
- Marketing start
- 2016-12-27
- Substance
- ZIPRASIDONE HYDROCHLORIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ziprasidone Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ZIPRASIDONE HYDROCHLORIDE | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 216X081ORU |
| Rxcui | 313776 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3563-3 | Ziprasidone Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3563 | ZIPRASIDONE HYDROCHLORIDE CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 1 | Current NDC, 1 package rows | 20240126_0fcebd61-25b2-d287-e063-6394a90a7b9a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-3563-3 | 68071356303 | 30 CAPSULE in 1 BOTTLE (68071-3563-3) | 30 capsule | 2024-01-25 | No | No | Current |